SCHEMBL8472452

SCHEMBL8472452

COc1ccc(-c2ccc3c(c2C(=O)O)OCO3)cc1

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.48
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
KMT2A Q03164 1/20 0.44
EDNRA P25101 4/20 0.44
POLB P06746 1/20 0.44
EDNRB P24530 2/20 0.43
NPC1 O15118 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656725 0.77 NR4A2 (0.45) SMN1; SMN2KDM4EALDH1A1HPGDKMT2A
SCHEMBL8081515 0.77 EDNRA (0.45) KDM4EALDH1A1HPGDKMT2AEDNRA
SCHEMBL8084890 0.76 EDNRA (0.45) KDM4EALDH1A1HPGDEDNRAEDNRB
SCHEMBL7656191 0.76 CFTR (0.47) SMN1; SMN2KDM4EALDH1A1HPGDKMT2A
SCHEMBL8072530 0.75 GPR35 (0.46) SMN1; SMN2KDM4EALDH1A1HPGDKMT2A
SCHEMBL27940177 0.74 CTNNB1 (0.41) SMN1; SMN2ALDH1A1HPGDKMT2APOLB
SCHEMBL10431721 0.71 FOLH1 (0.49) KDM4EALDH1A1POLBL3MBTL1
SCHEMBL7659425 0.71 PLAU (0.44) SMN1; SMN2KDM4EALDH1A1HPGDNPC1
SCHEMBL7681510 0.70 BACE1 (0.43) SMN1; SMN2KDM4EALDH1A1HPGDKMT2A
SCHEMBL7659665 0.70 GRM2 (0.54) SMN1; SMN2KDM4EALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5948817-A Polycyclic ethyl alkylamide melatonergic agents BRISTOL-MYERS SQUIBB COMPANY (US) 1999-09-07 US disclosed
WO-1998038991-A1 POLYCYCLIC ETHYL ALKYLAMIDE MELATONERGIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-09-11 WO disclosed